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ovarian tumors and in 90% of the cases are unilateral. Here, we describe a rare case of a bilateral ovarian
ﬁbrothecoma in a postmenopausal woman who presented with a large pelvic mass and metrorrhagia.
Diagnostic evaluation and surgical management are discussed along with a brief review of the literature.
Although rare, ovarian ﬁbrothecoma should be considered in patients presentingwith a large pelvicmass
andpostmenopausal bleeding. Radical surgery is the preferredmanagement strategy for postmenopausal
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. Introduction
Sex cord-stromal tumors are a distinct group of ovarian tumors
epresenting approximately 8% of all ovarian neoplasms. These
umors are of gonadal cell types which are derived from the
oelomic epithelium or the mesenchymal cells of the embryonic
onads. Themost common types are granulosa cell tumors, ﬁbroth-
comas and Sertoli-Leydig cell tumors.1 These tumors affect all
ge groups and in 70% of the cases the patients are diagnosed as
aving stage I lesions at presentation, contrary to the epithelial
varian tumorswhere patients presentwith stage III or IV disease.2
urgical resection is the preferred treatment for sex cord-stromal
umors and is generally associatedwithagoodprognosis.2 Here,we
escribe a rare case of a bilateral ovarian ﬁbrothecoma in a 54 year-
ld woman who presented with postmenopausal bleeding and a
arge pelvic mass.
. Presentation of case
A54-year-oldpostmenopausalwomanpresentedwitha2-week
istory of metrorrhagia and a large pelvic mass associated with
ull lower abdominal pain. She had gone through the menopause
t age of 45 and was not taking any hormone replacement. Her
ast medical history was signiﬁcant for arterial hypertension and
ypothyroidism.
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On physical examination a large non tender, well-deﬁned mass
was palpated in the pelvis. The haemogram revealed anemia with
a haemoglobin level of 9.0 g/dL and a haematocrit of 28.9%. Bio-
chemical investigations, tumormarkers and hormonal valueswere
within normal limits. Computed tomography (CT) revealed a large
lobular pelvic mass measuring 15 cm×12 cm probably originating
from the right ovary in contact with the anterior uterine sur-
face (Fig. 1). Hysteroscopy demonstrated endometrial polyps. At
exploratory laparotomy bilateral ovarian tumors were found and
a total hysterectomy with bilateral salpingo-oophorectomy was
performed (Fig. 2). Histopathological examination of both ovarian
tumors measuring 16 cm×12 cm×7.5 cm (right) and 2 cm×3 cm
(left) revealed hypercellularity but pleiomorphism andmitotic rate
were minimal (Fig. 3). A detailed immunohistochemical analysis
demonstrated that the tumor cells were stained strongly positive
for Vimentin, focally positive for Inhibin (Figs. 4 and 5) whereas
a negative staining for Desmin, Actin and CD68 was noted. In
addition, ki67 proliferation rate was low. Based on these ﬁnd-
ings the diagnosis of bilateral ovarian ﬁbrothecomas was made. In
addition, endometrialpolyposis andnumerousmyometrial leiomy-
omaswere also detected. Postoperative coursewas uneventful. The
patient is well and asymptomatic 8 months after surgery.
Open access under CC BY-NC-ND license.3. Discussion
Ovarian ﬁbrothecomas are uncommon tumors of gonadal stro-
mal cell origin accounting for 3–4% of all ovarian tumors.3,4 They
are rarely malignant5,6 and in 90% of the cases are unilateral.4
ense.
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Fig. 1. Computed tomography scan of the abdomen demonstrating a large lobular
pelvic mass.
Fig. 2. Postoperative photo showing the total hysterectomy and bilateral salpingo-
oophorectomy specimen. The resected portion of greater omentum was found
attached to the right large ovarian ﬁbrothecoma.
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Fig. 4. On immunohistochemical analysis the tumor cells were stained strongly
positive for Vimentin (original magniﬁcation 40×).ig. 3. Histopathological ﬁndings of ovarian ﬁbrothecoma. The tumor is hypercer-
ullar but pleomorphism and mitotic rate are minimal (H&E stain).Ovarian ﬁbrothecomas are composed of an admixture of
brous and thecomatous elements.7 Histologically, these tumors
re characterized by the presence of spindle, oval or round
ells forming various amounts of collagen5 and also containFig. 5. On immunohistochemical analysis the tumor cells were stained focally pos-
itive for Inhibin (original magniﬁcation 40×).
a smaller population of theca cells that contain intracellular
lipid.3
Edema and cystic degeneration are relatively common espe-
cially in large ﬁbrothecomaswhereas calciﬁcation and hemorrhage
are rarely observed.3,5 On gross examination the tumor has awhite
whorled appearance closely resembling uterine leiomyomas.3 The
tumor may be spherical or lobulated and is covered by intact ovar-
ian mucosa.8
Fibrothecomas occur predominately in older postmenopausal
women.4 They may be associated with Meigs syndrome, charac-
terized by the presence of hydrothorax and ascites8 and elevated
CA 125 levels.7 Clinical presentation is often non speciﬁc8 while
patients most commonly present with a pelvic mass, metrorrha-
gia and pelvic pain.9 Torsion is not an uncommon presentation
occurring in 8% of the patients.9
Endocrine manifestations due to hormonally active tumors are
rare.4 In case the ﬁbrothecoma displays estrogenic activity, associ-
ated uterine changes such as uterine enlargement and endometrial
thickening may be demonstrated mainly on Magnetic Resonance
Imaging (MRI) imaging.5,8
On CT scan, ovarian ﬁbrothecomas may appear as a homoge-
nous solid tumor with varying degrees of enhancement.10 In 79%
of the cases the tumor appears as a solid mass with delayed accu-
mulation of contrast medium, while in 21% of the cases the tumor
is partly or mainly cystic thus making differential diagnosis from
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ther ovarian masses, such as serous cystadenoﬁbromas or even
alignant tumors, difﬁcult.9 The absence of arterial vessels and the
bsence or slight early uptake of contrast enhancement are char-
cteristic signs and may be useful in considering the diagnosis of
ﬁbrothecoma preoperatively.9 On MRI, ﬁbrothecomas typically
how predominantly low signal intensity on T2-weighted images.3
Differential diagnosis of ﬁbrothecomas includes peduncu-
ated and intraligamentous leiomyomas and other solid ovarian
asses such as Brenner tumors, granulosa cell tumors and
ysgerminomas.3,5,8 In the presence of extensive cystic degener-
tion, the ﬁbrothecoma can be easily mistaken for a malignant
varian tumor.8 Thus, an accurate preoperative diagnosis by MRI
ay prevent an excessive surgical intervention. The characteristic
eature of ﬁbrothecomawith extensive cystic degeneration onMRI
maging is the presence of a solid portion that exhibits distinct low
ignal intensity on both T-1 and T-2 weighted images and slight
nhancement on post contrast enhanced images.8
Early diagnosis and surgical resection is the treatment of choice
or ovarian ﬁbrothecomas.10 Tumorectomy is indicated for young
atients while radical surgery in terms of bilateral salpingo-
ophorectomy is indicated for perimenopausal and menopausal
atients.4
. Conclusions
Bilateral ovarian ﬁbrothecoma is a rare occurrence. Ovarian
brothecoma should be considered in women presenting with
ostmenopausal bleeding, pelvic pain and a largepelvicmass. Radi-
al surgical excision is the preferred treatment for postmenopausal
omen and is associated with a good prognosis.
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